| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Lei Ding | Q91651640 |
| P2093 | author name string | Chang Xu | |
| Kun Wang | |||
| Wenxia Li | |||
| Yuhan Ding | |||
| Mengdi Hao | |||
| P2860 | cites work | Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer | Q24604601 |
| Digital PCR | Q24685020 | ||
| Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer | Q27851456 | ||
| Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
| The role of lymphangiogenesis and angiogenesis in tumor metastasis | Q28067309 | ||
| Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility | Q28082750 | ||
| Quantitative and sensitive detection of rare mutations using droplet-based microfluidics | Q28238121 | ||
| Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing | Q28280303 | ||
| Circulating mutant DNA to assess tumor dynamics | Q28289337 | ||
| Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer | Q28298328 | ||
| KRAS-dependent sorting of miRNA to exosomes | Q28646719 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA | Q29620083 | ||
| Origins, structures, and functions of circulating DNA in oncology | Q30249103 | ||
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data | Q30779447 | ||
| Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells | Q30908848 | ||
| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. | Q33590850 | ||
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. | Q33663019 | ||
| KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer | Q34066371 | ||
| Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer | Q34100603 | ||
| Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury | Q34224506 | ||
| Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer | Q34398320 | ||
| Integrated digital error suppression for improved detection of circulating tumor DNA | Q34520008 | ||
| Tumor-derived circulating endothelial cell clusters in colorectal cancer | Q34532337 | ||
| Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | Q34533164 | ||
| Neoplastic characteristics of the DNA found in the plasma of cancer patients | Q34543792 | ||
| Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. | Q34645569 | ||
| Plasma processing conditions substantially influence circulating microRNA biomarker levels | Q34769479 | ||
| Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer | Q34790678 | ||
| Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. | Q35078413 | ||
| Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. | Q35127938 | ||
| Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. | Q35475513 | ||
| Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer | Q35863159 | ||
| Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer | Q36086105 | ||
| Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care | Q40022390 | ||
| 293tExosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection. | Q40041215 | ||
| Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer | Q40069057 | ||
| Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. | Q40130589 | ||
| Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. | Q40255202 | ||
| Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer | Q40364937 | ||
| Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients | Q41136357 | ||
| Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. | Q41868457 | ||
| Inferring expressed genes by whole-genome sequencing of plasma DNA. | Q42774378 | ||
| Challenges in circulating tumour cell research | Q43500645 | ||
| Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing | Q44576396 | ||
| Capture of viable circulating tumor cells in the liver of colorectal cancer patients. | Q45819007 | ||
| Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing | Q46302330 | ||
| The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer. | Q47140501 | ||
| Methylation patterns in serum DNA for early identification of disseminated breast cancer | Q47151765 | ||
| The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. | Q47250388 | ||
| Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer | Q47311072 | ||
| Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System? | Q47563363 | ||
| Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. | Q47725182 | ||
| Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival | Q47914559 | ||
| Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria. | Q47925636 | ||
| Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer | Q48210303 | ||
| Detection and localization of surgically resectable cancers with a multi-analyte blood test. | Q48216212 | ||
| Circulating tumour DNA, a promising biomarker for the management of colorectal cancer | Q49836611 | ||
| Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. | Q50115874 | ||
| Molecular characterization of circulating tumor cells-from bench to bedside. | Q50128566 | ||
| Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer. | Q50592090 | ||
| Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. | Q53073587 | ||
| An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples. | Q53273734 | ||
| Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer. | Q53584921 | ||
| Importance of circulating tumor cells in newly diagnosed colorectal cancer. | Q53642128 | ||
| Analysis of circulating microRNA: preanalytical and analytical challenges. | Q54378210 | ||
| Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. | Q55043149 | ||
| Free DNA in the serum of cancer patients and the effect of therapy. | Q55492005 | ||
| Expression profile of miR-17/92 cluster is predictive of treatment response in rectal cancer | Q57053330 | ||
| The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios | Q57175454 | ||
| Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients | Q57280718 | ||
| Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review | Q58114470 | ||
| Current and future perspectives of liquid biopsies in genomics-driven oncology | Q58586693 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis | Q60300793 | ||
| The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases | Q60950127 | ||
| Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer | Q61917169 | ||
| Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells | Q64054850 | ||
| The role of SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer | Q64055290 | ||
| Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer | Q64061302 | ||
| Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer | Q64247100 | ||
| Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation | Q78713979 | ||
| Transrenal nucleic acids: from proof of principle to clinical tests | Q82218544 | ||
| The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke | Q82734214 | ||
| Circulating tumor cells count predicts survival in colorectal cancer patients | Q85651687 | ||
| Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise | Q87981791 | ||
| MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review | Q88934112 | ||
| Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients | Q89143210 | ||
| Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis | Q89288772 | ||
| Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival | Q89543422 | ||
| Circulation patterns and seed-soil compatibility factors cooperate to cause cancer organ-specific metastasis | Q90714254 | ||
| Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer | Q90767399 | ||
| Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients | Q90975000 | ||
| Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposure | Q91006681 | ||
| Neutrophils escort circulating tumour cells to enable cell cycle progression | Q91387375 | ||
| Exosomal circRNAs: biogenesis, effect and application in human diseases | Q91660350 | ||
| Roles of exosomes in metastatic colorectal cancer | Q91766833 | ||
| Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer | Q91879561 | ||
| Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer | Q91883674 | ||
| A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer | Q92026650 | ||
| Circulating biomarkers for early detection and clinical management of colorectal cancer | Q92685761 | ||
| Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial | Q92829025 | ||
| Circulating microRNAs as Promising Biomarkers in Colorectal Cancer | Q93108858 | ||
| ??? | Q94720111 | ||
| Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration | Q36087929 | ||
| Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas | Q36104229 | ||
| Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients | Q36104839 | ||
| Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study | Q36229421 | ||
| Noninvasive monitoring of infection and rejection after lung transplantation | Q36238500 | ||
| RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics | Q36278318 | ||
| Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. | Q36322381 | ||
| Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients | Q36586155 | ||
| Circulating tumor cells (CTC) detection: clinical impact and future directions. | Q36741696 | ||
| Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients | Q36796137 | ||
| A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases | Q36838055 | ||
| Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. | Q36998629 | ||
| The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis | Q37015727 | ||
| Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. | Q37075334 | ||
| Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer | Q37174021 | ||
| Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing | Q37198902 | ||
| Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. | Q37206520 | ||
| Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients | Q37236468 | ||
| Circulating tumor cells capture disease evolution in advanced prostate cancer. | Q37661448 | ||
| Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer | Q37681109 | ||
| A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer | Q37744279 | ||
| Circulating tumor cells: liquid biopsy of cancer | Q38046735 | ||
| Enrichment, detection and clinical significance of circulating tumor cells | Q38102590 | ||
| Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial | Q38385410 | ||
| Accessing Genetic Information with Liquid Biopsies | Q38602781 | ||
| Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis | Q38639822 | ||
| Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing | Q38729093 | ||
| Clinical and biological significance of circulating tumor cells in cancer | Q38743200 | ||
| Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. | Q38927321 | ||
| Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again? | Q38949879 | ||
| Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape | Q38958563 | ||
| Liquid Biopsies, What We Do Not Know (Yet). | Q39135342 | ||
| Liquid biopsies come of age: towards implementation of circulating tumour DNA. | Q39149201 | ||
| Integrating liquid biopsies into the management of cancer | Q39157824 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | colorectal cancer | Q188874 |
| local neoplasm recurrence | Q54945651 | ||
| colorectal neoplasm | Q58833976 | ||
| P304 | page(s) | 6843180 | |
| P577 | publication date | 2020-03-09 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Perspectives of the Application of Liquid Biopsy in Colorectal Cancer | |
| P478 | volume | 2020 |
Search more.